Gail Risbridger
Monash University
H-index: 69
Oceania-Australia
Top articles of Gail Risbridger
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Carboplatin in Metastatic Castrate Resistant Prostate Cancer: A retrospective study of heavily pre-treated patients (COMPACT) | Clinical Genitourinary Cancer | Lara Pemberton Connor Allen Eleanor Handel Andrew Weickhardt Jeremy Shapiro | 2024/1/22 |
Patient-derived castration-resistant prostate cancer model revealed CTBP2 upregulation mediated by OCT1 and androgen receptor | BMC Cancer | Daisuke Obinata Kenichi Takayama Mitchell G Lawrence Daigo Funakoshi Makoto Hara | 2024/12 |
Defining the challenges and opportunities for using patient‐derived models in prostate cancer research | W Nathaniel Brennen Clémentine Le Magnen Sofia Karkampouna Nicolas Anselmino Nathalie Bock | 2024/5 | |
Co‐targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor‐null prostate cancer | The Journal of Pathology | Nicholas Choo Shivakumar Keerthikumar Susanne Ramm Daisaku Ashikari Linda Teng | 2024/4/5 |
Advances in preclinical models of prostate cancer for research discovery | Renea A Taylor Mitchell G Lawrence Gail P Risbridger | 2023/5/1 | |
PD04-02 USING GENOMIC AND TRANSCRIPTOMIC PROPERTIES TO DETERMINE ANDROGEN RESPONSE IN DUCTAL PROSTATE CANCERS AND DETERMINE EFFICACY OF POLY (ADP-RIBOSE) POLYMERASE INHIBITORS … | The Journal of Urology | Weranja Ranasinghe Melbourne Australia Patricia Troncoso Mitchell Lawrence Nicholas Choo | 2023/4 |
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants | Nature genetics | Anqi Wang Jiayi Shen Alex A Rodriguez Edward J Saunders Fei Chen | 2023/12 |
Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human prostate cancer models | Nature Communications | LH Porter JJ Zhu NL Lister SG Harrison S Keerthikumar | 2023/9/2 |
Abstract PR006: PMR-116, a novel inhibitor of ribosome biogenesis with antitumor activity in preclinical models of prostate cancer | Cancer Research | Alisee Huglo Shelley Hedwards Mitchell Lawrence Richard Rebello Ashlee Clark | 2023/6/2 |
The future of patient-derived xenografts in prostate cancer research | Mitchell G Lawrence Renea A Taylor Georgia B Cuffe Lisa S Ang Ashlee K Clark | 2023/6 | |
Single cell RNA analysis reveals heterogeneous sub populations in aggressive variants of prostate cancer | Cancer Research | Rosalia Quezada Urban Shivakumar Keerthikumar Ashlee K Clark Laura H Porter Mitchell G Lawrence | 2022/6/15 |
OCT1-target neural gene PFN2 promotes tumor growth in androgen receptor-negative prostate cancer | Scientific Reports | Daisuke Obinata Daigo Funakoshi Kenichi Takayama Makoto Hara Birunthi Niranjan | 2022/4/12 |
Neuroendocrine cells in prostate cancer correlate with poor outcomes: a systematic review and meta‐analysis | Ashwini Kannan David Clouston Mark Frydenberg Dragan Ilic Md Nazmul Karim | 2022/10 | |
Chimeric antigen receptor T-cell therapy in metastatic castrate-resistant prostate cancer | Mahasha PJ Perera Patrick B Thomas Gail P Risbridger Renea Taylor Arun Azad | 2022/1/20 | |
New approaches to targeting epigenetic regulation in prostate cancer | Daryl Thompson Nicholas Choo Damien M Bolton Nathan Lawrentschuk Gail P Risbridger | 2022/9/1 | |
Colorimetric detection of extracellular hydrogen peroxide using an integrated microfluidic device | Analytical Chemistry | Esma Dervisevic Nicolas H Voelcker Gail Risbridger Kellie L Tuck Victor J Cadarso | 2022/1/11 |
Potent stimulation of the androgen receptor instigates a viral mimicry response in prostate cancer | Cancer Research Communications | Mohammadreza Alizadeh-Ghodsi Katie L Owen Scott L Townley Damien Zanker Samuel PG Rollin | 2022/7/25 |
Hidden clues in prostate cancer–Lessons learned from clinical and pre-clinical approaches on diagnosis and risk stratification | Roxanne Toivanen Laura H Porter Zhuoer Li David Clouston Gail P Risbridger | 2022/1/1 | |
PMR-116, a novel inhibitor of ribosome biogenesis with antitumor activity in preclinical models of prostate cancer | Cancer Research | Alisee Huglo Richard Rebello Mitchell Lawrence Gail Risbridger Denis Drygin | 2022/6/15 |
Post-transcriptional gene regulation by MicroRNA-194 promotes neuroendocrine transdifferentiation in prostate cancer | Cell reports | Rayzel C Fernandes John Toubia Scott Townley Adrienne R Hanson B Kate Dredge | 2021/1/5 |
Co-Authors
